1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Slovenia Pharmaceuticals and Healthcare Report Q3 2016

Slovenia Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 78 pages

Includes 3 FREE quarterly updates

BMI View: Slovenia's disease profile is attractive for innovative drugmakers as non-communicablediseases pose a great burden. Much like those of its Western European neighbours, Slovenia's health profileis dominated by cancer and cardiovascular diseases in particular. However, despite an attractiveepidemiological profile, the country's small population and market size will somewhat act as a deterrent toany major investment from multinationals.Headline Expenditure Projections

- Pharmaceuticals: EUR671mn (USD745mn) in 2015 to EUR666mn (USD713mn) in 2016; -0.7% inlocal currency terms and -4.3% in US dollar terms. Forecasts revised upwards compared to previousquarter.

- Healthcare: EUR3.44bn (USD3.82bn) in 2015 to EUR3.53bn (USD3.78bn) in 2016; 2.7% in localcurrency terms and -1.0% in US dollar terms. Forecasts revised upwards compared to previous quarter.

Table Of Contents

Slovenia Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Slovenia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Slovenia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Slovenia 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Slovenia 2014-2020) 30
Industry Risk/Reward Index 31
Central And Eastern Europe Risk/Reward Index - Q3 2016 31
Slovenia Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Intellectual Property Issues 40
Pricing Regime 40
Reimbursement Regime 42
Market Overview 44
Healthcare Sector 45
Table: Healthcare Resources (Slovenia 2010-2015) 49
Table: Healthcare Personnel (Slovenia 2010-2015) 49
Table: Healthcare Activity (Slovenia 2010-2015) 50
Research and Development 50
Clinical Trials 50
Epidemiology 51
Competitive Landscape 54
Research-Based Industry 54
Table: Table: Multinational Market Activity 54
Generic Drugmakers 55
Company Profile 58
Krka 58
Lek (Novartis/Sandoz) 63
Demographic Forecast 67
Table: Population Headline Indicators (Slovenia 1990-2025) 68
Table: Key Population Ratios (Slovenia 1990-2025) 68
Table: Urban/Rural Population and Life Expectancy (Slovenia 1990-2025) 69
Table: Population By Age Group (Slovenia 1990-2025) 69
Table: Population By Age Group % (Slovenia 1990-2025) 70
Glossary 72
Methodology 74
Pharmaceutical Expenditure Forecast Model 74
Healthcare Expenditure Forecast Model 74
Notes On Methodology 75
Risk/Reward Index Methodology 76
Index Overview 77
Table: Pharmaceutical Risk/Reward Index Indicators 77
Indicator Weightings 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.